Module 14B CNS Flashcards
Epilepsy
- Neurological disorder
- Brief disturbances in brain electrical activity
- Sudden brief seizure
- Varying intensities
Seizure
- Alteration of behaviour
- Caused by CNS dysfunction
- Sudden & transient
Epileptic Seizure
- Caused by primary CNS dysfunction
- Excess depolarization
- Hypersynchronization of neurons
Non-Epileptic Seizure
- Seizure like episode
- Not caused by abnormal electrical brain activity
Status Epilepticus
- Unremitting epileptic seizure
- Duration longer than 30 mins
- Frequent seizures without recovery/awareness
Focal/Partial Seizures
- Occur in 1 area of brain
Simple Partial Seizure
- No loss of consciousness
- Symptoms dependent on area of seizure activity
Complex Partial Seizure
- Involves loss of consciousness
- Awake but not aware of surroundings
- Symptoms dependent on area of seizure activity
Generalized Seizure
- Bilateral diffuse onset, arise from all brain areas
Types of Generalized Seizures
- Absence
- Tonic/clonic
- Myoclonic
- Tonic
- Atonic
Absence Seizures
- Loss of consciousness
- Behavioural arrest/staring
- Brief, occur in clusters (multiple per day)
- No association with automatisms
- Common in childhood
Tonic/Clonic Seizures
- Abrupt loss of consciousness
- Tonic period of 1 min (rigid muscles)
- Clonic period of 2-3 mins (involuntary muscle contraction)
- Incontinent state/tongue biting
- Drowsy/confused/headache post seizure
Myoclonic Seizures
- Sudden, brief muscle contraction (any muscle group)
- No loss of consciousness
- Associated with later development of tonic/clonic seizure
Tonic Seizures
- Sudden muscle rigidity
- Consciousness impairment
Atonic Seizures
- Sudden loss of muscle tone
- Duration 15 secs
- Drop to ground (fall injury risk)
Secondary Generalized Seizures
- Begins in 1 are of brain and spreads
- Focal phase (primary) referred to as ‘aura’
Frontal Lobe
- Simple repetitive motor movements (primary motor cortex)
- Tonic posturing (supplemental motor structures)
- Behavioural automatisms with bilateral movement
Parietal Lobe
- Localized paresthesia (somatosensory cortex)
- Complex/widespread paresthesia (somatosensory association cortex)
- Multisensory hallucinations (high order sensory association areas)
Occipital Lobe
- Visual hallucinations
- Temporary blindness
- Reflex nystagmus (involuntary eye movement)
- Simple seizures mistaken for migraines (similar symptoms)
Temporal Lobe
- Emotions & psychic symptoms
- Auditory, olfactory, gustatory hallucinations
- Visual distortions
- Paresthesia (numbness)
Epileptogenesis Classes
- Symptomatic (identified physical cause)
- Idiopathic (no identified cause)
- Cryptogenic (underlying cause likely but not identified)
Seizure Threshold
- Balance between excitable/inhibitory forces in brain
- Susceptibility to having a seizure
- Threshold must be reached & AP fired to generate seizure
Affecting Factors of Seizure Threshold
- Stroke
- Head injury
- Drug/alcohol withdrawal
- Infection
- Tumour
- Severe fever
- Visual stimuli
Actions of AntiEpileptic Drugs (AED)
- Blocking sodium channels
- Blocking voltage-dependent calcium channels
- Glutamate antagonists
- Potentiating actions of GABA
Sodium Channel Blocking
- Prolong inactivation state of Na+ channel
- Neurons fire at low frequency
Phenytoin
- Most common AED
- Blocks sodium channels
- Treatment for all seizure types (excludes absence)
- Non-linear kinetics (limited liver metabolism)
- Narrow therapeutic range (monitoring)
- Teratogenic
Adverse Effects of Phenytoin
- Sedation
- Gingival hyperplasia
- Skin rash
Blocking Voltage-Dependent Calcium Channels
- Inhibition of Ca++ channels
- Suppress neurotransmitter release
Glutamate Antagonists
- Decreases CNS excitation
- Treatment target AED’s
- Binds to NMDA/AMPA receptor acts as block
GABA Receptor
- Inhibitory CNS neurotransmitter
- Binding to receptor causes Cl- ions into cell
- More difficult to reach threshold
Potentiating Actions of GABA
- Increase inhibitory stimuli
- Suppress seizure activity
Types of GABA Potentiating Actions
- Enhancing GABA binding to receptor
- Stimulating GABA release
- Inhibiting GABA reuptake
- Inhibiting GABA metabolism
AntiEpileptic Drugs
- Classified as traditional or newer
- Effects similar between classes
- Newer have decrease side effects
- Decrerased induction of hepatic metabolizing enzymes
Depression Diagnosis
- 5+ of following symptoms present
- Depressed mood most of day, everyday
- Loss of interest/pleasure
- Weight gain/loss
- Insomnia/hypersomnia
- Psychomotor agitation/retardation
- Fatigue/energy loss
- Worthlessness
- Excessive guilt
- Death/suicidal thoughts
- Decreased ability to think, concentrate
Exogenous Depression
- Prolonged grieving & excessive guilt (pathological)
- Prolonged depression following failure/rejection (adjustment)
Endogenous Depression
- Major depression
- Severe depression
- Atypical depression
- Dysthymia
- Seasonal affective disorder (SAD)
- Postpartum depression
- Bipolar
Major Depression
- Loss of interest
- Lack of response to positive stimuli
- Insomnia
- Weight loss
- Worse in AM
Severe Depression
- Similar to major
- In addition, suicidal ideation & psychoses
Atypical Depression
- Similar to major
- Hypersomnia & hyperphagia
- Obesity
Dysthymia
- Mood regularly low (less severe than major)
- Noticeable to those close to patient
- Response psychotherapy over drugs
Seasonal Affective Disorder (SAD)
- Mild or moderate depression symptoms
- Associated with lack of sunlight (winter months)
Postpartum Depression
- Moderate to severe depression after giving birth
- 3 months-1 year after birth
Bipolar Disorder
- Alternating periods of elevated/irritable mood
- Periods of depression
Monoaime Hypothesis
- Altered monoxime release
- Receptor sensitivity
- Post-synaptic function
- Lead to depression symptoms
Antidepressants
- Increase synaptic levels of monoamine neurotransmitters
- Inhibiting monoamine reuptake or metabolism
Antidepressant Classes
- Tricyclic antidepressants
- Selective serotonin reuptake inhibitors (SSRI)
- Selective serotonin/norepinephrine reuptake inhibitors (SNRI)
Monoamine oxidase inhibitors (MAOI)
Tricyclic Antidepressants
- Inhibit reuptake of serotonin & norepinephrine
- Effective treatment of major depression
- Chemical structure has three rings
Adverse Effects of Tricyclic Antidepressants
- Anticholinergic effects
- Sedation
- Orthostatic hypotension
- Decreased seizure threshold
- Cardiac toxicity
- Weight gain
- Sexual dysfunction
Selective Serotonin Reuptake Inhibitors (SSRI)
- Similar efficacy to TCAs
- Block only serotonin reuptake
- Less side effects than TCAs
- Common major depression treatment
Adverse Effects of SSRIs
- Weight gain
- Sexual dysfunction
- Insomnia
- Serotonin syndrome (agitation, confusion, anxiety, hallucinations)
Selective Serotonin/Norepinephrine Reuptake Inhibitors (SNRIs)
- Block reuptake of serotonin & norepinephrine
- Effective treatment of major depression
- Faster onset of action
- Mechanism of action similar to TCA’s
Adverse Effects of SNRIs
- Nausea
- Diastolic hypertension
- Sexual dysfunction
Monoamine Oxidase Inhibitors (MAOI)
- Inactivates monoamine neurotransmitters A&B
- MAO-A metabolizes serotonin & norepinephrine
- MOA-B metabolizes dopamine
- Treatment of atypical & dysthymia
Inhibiting monoamine metabolism is pre-synaptic neuron
Adverse Effects of MAOIs
- CNS excitation
- Orthostatic hypotension
- Hypertensive crisis (combined with tyramine foods)
Manic Phase Symptoms
- Irritation
- Inflated self-esteem
- Little need for sleep
- Poor control of temper
- Reckless behaviour
- Easily distracted
Bipolar Drug Treatment
- Mood stabilizers
- Antipsychotics
- Antidepressants
Mood Stabilizers
- Relieve symptoms during manic/depressive episodes
- Prevent recurrence of episodes
- Doesn’t worsen or alter rate of episodes
Lithium & valproic acid
Lithium Usage
- Alters uptake/release of glutamate
- Blocks serotonin binding
- Narrow therapeutic range
- Plasma conc altered by Na+
- Na+ loss increase lithium conc
Antipsychotics
- Control symptoms during manic episodes
- Stabilize mood (long term)
- Lower risk of extrapyramidal symptoms
Antidepressants
Antidepressants
- Treatment of depressive episode
- Combined with mood stabilizer
Anxiety
- Normal physiological response to stress
- Symptoms create functional impairment on daily living
- Linked closely with depression
Anxiety Types
- General anxiety disorder
- Panic disorder
- Agoraphobia
- Obsessive-compulsive disorder (OCD)
- Social anxiety disorder
- Post-traumatic stress disorder (PTSD)
- Simple phobia
General Anxiety Disorder
- Overwhelmed with uncontrollable worrying
- Unrealistic/excessive worry
- Last 6+ months
Panic Disorder
- Sense of impending doom unrelated to stressors
- Panic attacks (SOB, chest pain, dizziness)
- Confused with heart attack
Agoraphobia
- Feeling judged
- Situational escaping feels difficult/embarrassing
Obsessive Compulsive Disorder (OCD)
- Obsession/compulsion
- Interfere with daily life
PTSD
- Anxiety occurring after traumatic event
- Re-experiencing event
- Insomnia
Simple Phobia
- Related to specific fear
Anxiety Drug Treatment
- Benzodiazepines (BDZ)
- Buspirone
- Antidepressants
Benzodiazepines (BDZ)
- First line therapy for anxiety
- Potentiating actions of GABA & GABA receptor
- Increased binding of GABA to receptor
- Cl- moves into cell
- CNS depression
Benzodiazepine Uses
- Anxiety (generalized & social)
- Seizures
- Insomnia (higher dose)
- Alcohol withdrawal
- Muscle spasm
Adverse Effects of Benzodiazepines
- CNS depression (drowsiness, concentration difficulty)
- Anterograde amnesia (impaired memory following dosing)
- Respiratory depression (combined with alcohol)
- Teratogenic
- Tolerance
- Withdrawal
Buspirone
- Modulation of serotonergic/dopaminergic neurotransmission
- Treatment of generalized anxiety
- No signs of tolerance/physical dependence
- Anxiolytic effects develop slowly
- Well tolerated
Generalized Anxiety Treatment
- SSRI & SNRI
- Buspirone
- Slow to generate effect
Panic/Agoraphobia Treatment
- SSRI, TCA, MAO inhibitor
- 6-12 weeks to take effect
- SSRIs tolerated best
OCD Treatment
- SSRIs
- Behavioral therapy
Social Anxiety Treatment
- SSRIs long term
- BDZs immediate relief
PTSD Treatment
- No evidence of effective drug treatment
- Therapy